VIDEOS & PUBLICATIONS IMPROVING LIVES

Opening up new fields of medical science

Selected videos on HalioDx

Discover HalioDx - Reportage by Grand Luminy Technopole - April 2017
Immunoscore® Colon Symposium - June 1, 2018, Chicago | Stanley Hamilton, MD
Immunoscore® Colon Symposium - June 1, 2018, Chicago | Jêrome Galon, PhD
Immunoscore® Colon Symposium - June 1, 2018 Discussion on clinical cases with David Malka, MD, PhD & Marc Van Den Eynde, MD, PhD
Dr Jerome Galon on the Prognostic Value of Immunoscore, Onclive - ASCO 2016
Webinar on “Clinical utility of Immunoscore® in colon cancer” with Marc Van Den Eynde, MD, PhD | October 17, 2017
Webinar on Immunoscore® Colon presented by Dr Jérôme Galon - July 2016
Webinar on Immunoscore® Colon analytical performance presented by Fabienne Hermitte | Nov 2016
Dr Jérôme GALON, Cordeliers Research Center - EUROBIOMED & MARSEILLE IMMUNOPOLE Event - Dec. 2015
Replay of the webinar on "Halioseek® PD-L1/CD8" beyond a simple PD-L1 testing. Performance and capacity to improve NSCLC patient stratification for Immune Checkpoint Inhibitors (ICI) treatments.

Main Publications

Angelova et al

Evolution of metastases in space and time under immune selection.

Cell 2018 ;

10.1016/j.cell.2018.09.018

More info

Pagès et al.

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

The Lancet, 2018

May 10, 2018

More info

Mlecnik B et al.

Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.

J Natl Cancer Inst. 2018.

Jan 1;110(1).

More info

Fridman WH et al.

The immune contexture in cancer prognosis and treatment.

Nat Rev Clin Oncol. 2017

Jul 25. 2017.101.

More info

Hermitte F

Biomarkers immune monitoring technology primer: Immunoscore® Colon

Journal for ImmunoTherapy of Cancer 2016

DOI: 10.1186/s40425-016-0161-x

More info

Galon J et al.

Validation of the Immunoscore (IM) as a prognostic marker in stage I/II/III colon cancer: Results of a worldwide consortium-based analysis of 1,336 patients.

2016 ASCO Annual Meeting

J Clin Oncol 34, 2016 (suppl; abstr 3500)

More info

Mlecnik B et al.

Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability.

Immunity. 2016 ;

Mar 15;44(3):698-711.

More info

Mlecnik B et al.

The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis.

Sci Transl Med. 2016 ;

24 Feb 2016, Vol. 8, Issue 327, pp. 327ra26.

More info

Berghoff AS et al.

Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases

OncoImmunology, 2016

Jun 9;5(1):e1057388.

More info

Bindea G et al.

Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.

Immunity. 2013 ;

39(4):782-95.

More info

Galon J et al.

The continuum of cancer immunosurveillance: prognostic, predictive and mechanistic signatures.

Immunity 2013 ;

39 : 11-26.

More info

Fridman WH et al.

The immune contexture in human tumors: impact on clinical outcome.

Nat Rev Cancer 2012 ;

12: 298-306.

More info

Mlecnik B et al.

Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

J Clin Oncol 2011 ;

29 : 610-8.

More info

Pagès F et al.

In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.

J Clin Oncol 2009 ;

27 : 5944-51.

More info

Galon J et al.

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.

Science 2006 ;

313 : 1960-4.

More info